Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Critical Care Medicine 2020-Jun

Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental BPD

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
リンクがクリップボードに保存されます
Kellen Hirsch
Elizabeth Taglauer
Gregory Seedorf
Carly Callahan
Erica Mandell
Carl White
Stella Kourembanas
Steven Abman

キーワード

概要

Background: Antenatal inflammation with placental dysfunction is strongly associated with high BPD risk in preterm infants. Whether antenatal or postnatal HIF augmentation can preserve lung structure and function and prevent pulmonary hypertension (PH) after intrauterine inflammation is controversial.

Objective: To determine if antenatal or postnatal prolyl-hydroxylase inhibitor (PHi) therapy increases lung HIF expression, preserves lung growth and function and prevents PH in a rat model of CA-induced BPD caused by antenatal inflammation.

Methods: Endotoxin was administered to pregnant rats by intra-amniotic (IA) injection at embryonic day 20 and pups were delivered by cesarean-section at E22. Selective PHi drugs, dimethyloxalylglycine (DMOG) or GSK360A (GSK), were administered into the amniotic space at E20 or after birth by intraperitoneal injection for 2 weeks. Placentas and lung tissue were collected at birth for morphometric and western blot measurements of HIF-1a, HIF-2a, vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) protein contents. At day 14, lung function was assessed, and tissues were harvested to determine alveolarization by radial alveolar counts(RAC) and pulmonary vessel density(PVD) and right ventricular hypertrophy(RVH).

Results: Antenatal PHi therapy preserves lung alveolar and vascular growth and lung function and prevents RVH after intrauterine ETX exposure. Antenatal administration of PHi markedly up-regulates lung HIF-1a, HIF-2a, VEGF and eNOS expression after ETX exposure.

Conclusions: HIF augmentation improve lung structure and function, prevents RVH and improves placental structure following antenatal ETX exposure. We speculate that antenatal or postnatal PHi therapy may provide novel strategies to prevent BPD due to antenatal inflammation.

Keywords: Hypoxia-inducible factors; bronchopulmonary dysplasia; chorioamnionitis; placenta; prolyl hydroxylase inhibitors.

Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge